Lucy To

Lucy To is an experienced finance professional with a strong background in leadership roles across several prominent organizations. Currently serving as Chief Financial Officer at SAB BIO, Lucy has previously held significant positions including Managing Director at Wells Fargo, Director at Deutsche Bank, and Director of Business Development at Intercept Pharmaceuticals. Additionally, Lucy contributed to Citigroup as Vice President, showcasing a diverse skill set in financial management and business development throughout a robust career in the financial services and biotechnology sectors.